Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

720 ARTÍCULOS , VIENDO DEL 406 AL 420

Adverse Events as a Cause of Unblinding of Allocated Arms in Anti-Amyloid Therapy Trials: A Meta-Analysis of the Predictive Value

Sato K, Niimi Y, Ihara R, Iwata A, Iwatsubo T.

J Alzheimers Dis. 2024;101(4):1127-1132. doi: 10.3233/JAD-240623.

Drug Repurposing for Effective Alzheimer's Disease Medicines: Existing Methods and Novel Pharmacoepidemiological Approaches

Roberts JA, Varma VR, Jones A, Thambisetty M.

J Alzheimers Dis. 2024;101(s1):S299-S315. doi: 10.3233/JAD-240680.

Neuropsychiatric Manifestations in Alzheimer's Disease Patients: Genetics and Treatment Options

Singh AK, Malviya R, Prakash A, Verma S.

CNS Neurol Disord Drug Targets. 2024;23(1):39-54. doi: 10.2174/1871527322666230301111216.

Alzheimer Disease Treatment With Acetylcholinesterase Inhibitors and Incident Age-Related Macular Degeneration

Sutton SS, Magagnoli J, Cummings TH, Hardin JW, Ambati J.

JAMA Ophthalmol. 2024 Feb 1;142(2):108-114. doi: 10.1001/jamaophthalmol.2023.6014.

Nanotechnology in the diagnostic and therapy for Alzheimer's disease

Panghal A, Flora SJS.

Biochim Biophys Acta Gen Subj. 2024 Mar;1868(3):130559. doi: 10.1016/j.bbagen.2024.130559. Epub 2024 Jan 6.

Changes in dementia treatment patterns associated with changes in the National Policy in South Korea among patients with newly diagnosed Alzheimer's disease between 2011 and 2017: results from the multicenter, retrospective CAPTAIN study

Kim YJ, So KY, Lee HM, Hahn C, Song SH, Lee YS, Kim SW, Park HC, Ryu J, Lee JS, Kang MJ, Kim J, Lee Y, Lee JH.

BMC Public Health. 2024 Jan 12;24(1):168. doi: 10.1186/s12889-024-17671-2.

Recent trends in treatment strategies for Alzheimer(')s disease and the challenges: A topical advancement

Liu N, Liang X, Chen Y, Xie L.

Ageing Res Rev. 2024 Feb;94:102199. doi: 10.1016/j.arr.2024.102199. Epub 2024 Jan 15.

Role of Imaging Genetics in Alzheimer's Disease: A Systematic Review and Current Update

Chhetri A, Goel K, Ludhiadch A, Singh P, Munshi A.

CNS Neurol Disord Drug Targets. 2024;23(9):1143-1156. doi: 10.2174/0118715273264879231027070642.

Therapeutic potential of curcumin on the cognitive decline in animal models of Alzheimer's disease: a systematic review and meta-analysis

Fan L, Zhang Z.

Naunyn Schmiedebergs Arch Pharmacol. 2024 Jul;397(7):4499-4509. doi: 10.1007/s00210-024-02946-7. Epub 2024 Jan 24.

Colony Stimulating Factor-1 Receptor: An emerging target for neuroinflammation PET imaging and AD therapy

Adhikari A, Chauhan K, Adhikari M, Tiwari AK.

Bioorg Med Chem. 2024 Feb 15;100:117628. doi: 10.1016/j.bmc.2024.117628. Epub 2024 Feb 1.

Vortioxetine Treatment for Depression in Patients with Prodromal vs Mild Alzheimer's Disease: A Six-Month, Open-Label, Observational Study

Padovani A, Caratozzolo S, Benussi A, Galli A, Rozzini L, Cosseddu M, Turrone R, Pilotto A.

J Prev Alzheimers Dis. 2024;11(2):375-381. doi: 10.14283/jpad.2023.132.

Assessment of Efficacy and Safety of Zagotenemab: Results From PERISCOPE-ALZ, a Phase 2 Study in Early Symptomatic Alzheimer Disease

Fleisher AS, Munsie LM, Perahia DGS, Andersen SW, Higgins IA, Hauck PM, Lo AC, Sims JR, Brys M, Mintun M; PERISCOPE-ALZ Site Investigators.

Neurology. 2024 Mar 12;102(5):e208061. doi: 10.1212/WNL.0000000000208061. Epub 2024 Feb 22.

Diagnosing epileptic seizures in patients with Alzheimer's disease and deciding on the appropriate treatment plan

Brigo F, Lattanzi S.

Expert Rev Neurother. 2024 Apr;24(4):361-370. doi: 10.1080/14737175.2024.2325038. Epub 2024 Mar 1.

[Multi-center open comparative randomized study of efficacy and safety of Akatinol Memantine 20 mg (single-doses) vs Akatinol Memantine 10 mg (double-doses) in patients with vascular dementia]

Gavrilova SI, Kolykhalov IV, Mikhaylova NM, Ponomareva EV, Fedorova YB, Medvedev VE, Frolova VI, Gushanskaya EV, Litvinenko IV, Emelin AY, Lobzin VY, Kashin AV, Tanashyan MM, Kachanova MV, Knyazev AV, Gonik MI.

Zh Nevrol Psikhiatr Im S S Korsakova. 2024;124(2):69-77. doi: 10.17116/jnevro202412402169.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias